Pelthos Therapeutics Inc.
PTHS
$23.06
-$0.14-0.60%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.80M | 7.41M | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.80M | 7.41M | -- | -- | -- |
| Cost of Revenue | 4.70M | 3.03M | 709.10K | 207.30K | 479.60K |
| Gross Profit | 12.10M | 4.38M | -709.10K | -207.30K | -479.60K |
| SG&A Expenses | 42.45M | 25.52M | 7.53M | 6.56M | 6.39M |
| Depreciation & Amortization | 1.56M | 679.00K | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.22M | 29.66M | 8.94M | 7.47M | 7.57M |
| Operating Income | -32.43M | -22.25M | -8.94M | -7.47M | -7.57M |
| Income Before Tax | -50.71M | -24.05M | -9.04M | -7.36M | -7.95M |
| Income Tax Expenses | -7.39M | -465.00K | -- | -- | -- |
| Earnings from Continuing Operations | -43.32 | -23.58 | -9.04 | -7.36 | -7.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.32M | -23.58M | -9.04M | -7.36M | -7.95M |
| EBIT | -32.43M | -22.25M | -8.94M | -7.47M | -7.57M |
| EBITDA | -25.79M | -15.01M | -- | -- | -- |
| EPS Basic | -20.77 | -17.09 | -14.71 | -12.40 | -14.65 |
| Normalized Basic EPS | -14.39 | -10.78 | -9.20 | -7.75 | -9.15 |
| EPS Diluted | -20.77 | -17.09 | -14.71 | -12.40 | -14.65 |
| Normalized Diluted EPS | -14.39 | -10.78 | -9.20 | -7.75 | -9.15 |
| Average Basic Shares Outstanding | 7.47M | 4.92M | 2.44M | 2.37M | 2.23M |
| Average Diluted Shares Outstanding | 7.47M | 4.92M | 2.44M | 2.37M | 2.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |